Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Acute flaccid myelitis

Peter J. Gill, Ari Bitnun and E. Ann Yeh
CMAJ December 03, 2018 190 (48) E1418; DOI: https://doi.org/10.1503/cmaj.181442
Peter J. Gill
Divisions of Paediatric Medicine (Gill), infectious Diseases (Bitnun) and Neurology (Yeh), The Hospital for Sick Children; Department of Paediatrics (Gill, Bitnun, Yeh), University of Toronto; Department of Pediatrics (Gill, Bitnun, Yeh), Division of Neurosciences and Mental Health (Yeh), SickKids Research Institute, University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ari Bitnun
Divisions of Paediatric Medicine (Gill), infectious Diseases (Bitnun) and Neurology (Yeh), The Hospital for Sick Children; Department of Paediatrics (Gill, Bitnun, Yeh), University of Toronto; Department of Pediatrics (Gill, Bitnun, Yeh), Division of Neurosciences and Mental Health (Yeh), SickKids Research Institute, University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Ann Yeh
Divisions of Paediatric Medicine (Gill), infectious Diseases (Bitnun) and Neurology (Yeh), The Hospital for Sick Children; Department of Paediatrics (Gill, Bitnun, Yeh), University of Toronto; Department of Pediatrics (Gill, Bitnun, Yeh), Division of Neurosciences and Mental Health (Yeh), SickKids Research Institute, University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Acute flaccid myelitis is a clinical syndrome characterized by rapid onset of muscle weakness

From January to November 2018, there were 90 confirmed cases of acute flaccid myelitis in the United States and 48 suspected cases in Canada.1,2 Injury to the anterior horn cells of the spinal cord causes abrupt-onset limb weakness, pain, paresthesias and areflexia.3 About 25% of patients develop cranial nerve or bulbar signs or both.4 It may resemble Guillain–Barré Syndrome, but can be distinguished by its typical appearance on magnetic resonance imaging (see point 3 below) and its motor distribution (asymmetric weakness in acute flaccid myelitis v. symmetric and ascending in Guillain–Barré Syndrome).3 Typically affecting children aged 4–15 years, it is usually preceded by a nonspecific viral prodrome3–5 (Box 16).

Box 1:

CDC case definition of AFM*,6

  • Confirmed AFM: acute focal limb weakness and MRI findings of mainly grey matter lesions involving one or more spinal cord segments.

  • Probable AFM: acute focal limb weakness and cerebrospinal fluid pleocytosis (> 5 cells/mm3).

  • Note: AFM = acute flaccid myelitis, CDC = Centers for Disease Control and Prevention, MRI = magnetic resonance imaging.

  • ↵* No age limitation.

Enteroviruses are the predominant cause in children

Clusters of acute flaccid myelitis occurred in North America in 2014, 2016 and 2018 during the late summer–fall months, coincident with peak enterovirus season.2,4 With the near eradication of polioviruses, EV-D68 and EV-A71 have emerged as the predominant viruses associated with acute flaccid myelitis.4 EV-D68 was likely responsible for the 2014 and 2016 clusters in North America,7 but no cause has been established for the 2018 cluster.

Infectious workup and neuroimaging should be performed urgently

Cerebrospinal fluid (CSF), respiratory and stool samples, and selectively blood, should be tested for enteroviruses. If infection is present, the CSF will show a lymphocytic pleocytosis and normal to mildly elevated protein.4 Magnetic resonance imaging with contrast of the brain and spine typically shows T2 hyperintensities in the grey matter of the spinal cord and, often, enhancement of the nerve roots. In Guillain–Barré Syndrome, nerve root enhancement is seen, but spinal cord grey matter is not involved. Electromyography and nerve conduction studies show acute motor axonal neuropathy.3 Suspected cases of acute flaccid myelitis should be reported to the Public Health Agency of Canada.

Acute flaccid myelitis is a medical emergency

Patients should be referred urgently to a tertiary care centre, as 24%–52% require admission to the intensive care unit for ventilatory or nutritional support or both.5,8 Treatment should be considered on a case-by-case basis and may include immunomodulatory therapy, such as high-dose intravenous corticosteroids, intravenous immunoglobulin and plasmapheresis.4 A vaccine has been developed for EV-A71 but is not licensed in Canada.4

Acute flaccid myelitis often results in residual impairment

Canadian and US studies have described persistent deficits in most children after 4–6 months’ follow-up, with full recovery in only 8%–18%, and 8%–14% either requiring assistive devices for ambulation or complete dependence on caregivers.5,8

Footnotes

  • CMAJ Podcasts: author interview at https://soundcloud.com/cmajpodcasts/181442-five

  • References: Available online at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.181442/-/DC1

  • Competing interests: None declared relating to this work.

  • This article has been peer reviewed.

  • Disclaimer: Peter Gill is a member of the Editorial Advisory Board for CMAJ and was not involved in the editorial decision-making process for this article.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 190 (48)
CMAJ
Vol. 190, Issue 48
3 Dec 2018
  • Table of Contents
  • Index by author

Podcast

Subscribe to podcast
Download MP3

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Acute flaccid myelitis
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Acute flaccid myelitis
Peter J. Gill, Ari Bitnun, E. Ann Yeh
CMAJ Dec 2018, 190 (48) E1418; DOI: 10.1503/cmaj.181442

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Acute flaccid myelitis
Peter J. Gill, Ari Bitnun, E. Ann Yeh
CMAJ Dec 2018, 190 (48) E1418; DOI: 10.1503/cmaj.181442
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Acute flaccid myelitis is a clinical syndrome characterized by rapid onset of muscle weakness
    • Enteroviruses are the predominant cause in children
    • Infectious workup and neuroimaging should be performed urgently
    • Acute flaccid myelitis is a medical emergency
    • Acute flaccid myelitis often results in residual impairment
    • Footnotes
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Pharyngeal tularemia acquired in an urban setting in Canada
  • Antithrombotic agents in patients with COVID-19
  • Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor
Show more Practice

Similar Articles

Collections

  • Sections
    • Five Things to Know About
  • Topics
    • Infectious diseases
    • Neurology
    • Pediatrics
    • Public health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire